Drug Shortage Report for ADMELOG SOLOSTAR

Last updated on 2023-06-15 History
Report ID 170355
Drug Identification Number 02469871
Brand name ADMELOG SOLOSTAR
Common or Proper name ADMELOG SOLOSTAR
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN LISPRO
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5 pens/box
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-09-27
Estimated end date 2023-07-31
Actual end date 2023-06-14
Shortage status Resolved
Updated date 2023-06-15
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’sSupply delay. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2023-06-15 French Compare
v10 2023-06-15 English Compare
v9 2022-11-10 French Compare
v8 2022-11-10 English Compare
v7 2022-10-31 French Compare
v6 2022-10-31 English Compare
v5 2022-10-24 French Compare
v4 2022-10-24 English Compare
v3 2022-09-28 English Compare
v2 2022-09-27 French Compare
v1 2022-09-27 English Compare

Showing 1 to 11 of 11